nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Cyclopentolate—BCHE—multiple sclerosis	0.00277	1	CrCbGaD
Hyoscyamine—Erythema—Triamcinolone—multiple sclerosis	0.00124	0.00138	CcSEcCtD
Hyoscyamine—Erythema—Methylprednisolone—multiple sclerosis	0.00123	0.00138	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.00123	0.00138	CcSEcCtD
Hyoscyamine—Angioedema—Prednisolone—multiple sclerosis	0.00123	0.00137	CcSEcCtD
Hyoscyamine—Myocardial infarction—Prednisone—multiple sclerosis	0.00123	0.00137	CcSEcCtD
Hyoscyamine—Hypersensitivity—Azathioprine—multiple sclerosis	0.00122	0.00136	CcSEcCtD
Hyoscyamine—Dysgeusia—Triamcinolone—multiple sclerosis	0.00121	0.00135	CcSEcCtD
Hyoscyamine—Nausea—Cladribine—multiple sclerosis	0.00121	0.00135	CcSEcCtD
Hyoscyamine—Vertigo—Prednisolone—multiple sclerosis	0.00121	0.00135	CcSEcCtD
Hyoscyamine—Syncope—Prednisolone—multiple sclerosis	0.00121	0.00135	CcSEcCtD
Hyoscyamine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00119	0.00133	CcSEcCtD
Hyoscyamine—Somnolence—Mitoxantrone—multiple sclerosis	0.00119	0.00133	CcSEcCtD
Hyoscyamine—Loss of consciousness—Prednisolone—multiple sclerosis	0.00118	0.00132	CcSEcCtD
Hyoscyamine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00118	0.00131	CcSEcCtD
Hyoscyamine—Convulsion—Prednisolone—multiple sclerosis	0.00117	0.0013	CcSEcCtD
Hyoscyamine—Fatigue—Mitoxantrone—multiple sclerosis	0.00115	0.00129	CcSEcCtD
Hyoscyamine—Arrhythmia—Dexamethasone—multiple sclerosis	0.00115	0.00128	CcSEcCtD
Hyoscyamine—Arrhythmia—Betamethasone—multiple sclerosis	0.00115	0.00128	CcSEcCtD
Hyoscyamine—Pain—Mitoxantrone—multiple sclerosis	0.00114	0.00128	CcSEcCtD
Hyoscyamine—Constipation—Mitoxantrone—multiple sclerosis	0.00114	0.00128	CcSEcCtD
Hyoscyamine—Bradycardia—Prednisone—multiple sclerosis	0.00114	0.00127	CcSEcCtD
Hyoscyamine—Diarrhoea—Azathioprine—multiple sclerosis	0.00113	0.00126	CcSEcCtD
Hyoscyamine—Angioedema—Triamcinolone—multiple sclerosis	0.00113	0.00126	CcSEcCtD
Hyoscyamine—Angioedema—Methylprednisolone—multiple sclerosis	0.00113	0.00126	CcSEcCtD
Hyoscyamine—Erythema—Dexamethasone—multiple sclerosis	0.00112	0.00125	CcSEcCtD
Hyoscyamine—Erythema—Betamethasone—multiple sclerosis	0.00112	0.00125	CcSEcCtD
Hyoscyamine—Hallucination—Prednisone—multiple sclerosis	0.00112	0.00125	CcSEcCtD
Hyoscyamine—Vertigo—Triamcinolone—multiple sclerosis	0.00111	0.00124	CcSEcCtD
Hyoscyamine—Syncope—Triamcinolone—multiple sclerosis	0.00111	0.00124	CcSEcCtD
Hyoscyamine—Vertigo—Methylprednisolone—multiple sclerosis	0.00111	0.00124	CcSEcCtD
Hyoscyamine—Syncope—Methylprednisolone—multiple sclerosis	0.00111	0.00123	CcSEcCtD
Hyoscyamine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.0011	0.00123	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.0011	0.00122	CcSEcCtD
Hyoscyamine—Oedema—Prednisolone—multiple sclerosis	0.0011	0.00122	CcSEcCtD
Hyoscyamine—Dysuria—Methotrexate—multiple sclerosis	0.0011	0.00122	CcSEcCtD
Hyoscyamine—Dizziness—Azathioprine—multiple sclerosis	0.0011	0.00122	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00109	0.00122	CcSEcCtD
Hyoscyamine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00109	0.00121	CcSEcCtD
Hyoscyamine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00109	0.00121	CcSEcCtD
Hyoscyamine—Shock—Prednisolone—multiple sclerosis	0.00108	0.0012	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00108	0.0012	CcSEcCtD
Hyoscyamine—Convulsion—Triamcinolone—multiple sclerosis	0.00107	0.0012	CcSEcCtD
Hyoscyamine—Tachycardia—Prednisolone—multiple sclerosis	0.00107	0.0012	CcSEcCtD
Hyoscyamine—Convulsion—Methylprednisolone—multiple sclerosis	0.00107	0.00119	CcSEcCtD
Hyoscyamine—Urticaria—Mitoxantrone—multiple sclerosis	0.00106	0.00119	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00106	0.00118	CcSEcCtD
Hyoscyamine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00106	0.00118	CcSEcCtD
Hyoscyamine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00106	0.00118	CcSEcCtD
Hyoscyamine—Vomiting—Azathioprine—multiple sclerosis	0.00105	0.00117	CcSEcCtD
Hyoscyamine—Anxiety—Methylprednisolone—multiple sclerosis	0.00105	0.00117	CcSEcCtD
Hyoscyamine—Drowsiness—Methotrexate—multiple sclerosis	0.00105	0.00117	CcSEcCtD
Hyoscyamine—Rash—Azathioprine—multiple sclerosis	0.00104	0.00116	CcSEcCtD
Hyoscyamine—Dermatitis—Azathioprine—multiple sclerosis	0.00104	0.00116	CcSEcCtD
Hyoscyamine—Depression—Methotrexate—multiple sclerosis	0.00104	0.00116	CcSEcCtD
Hyoscyamine—Flushing—Prednisone—multiple sclerosis	0.00104	0.00116	CcSEcCtD
Hyoscyamine—Headache—Azathioprine—multiple sclerosis	0.00104	0.00116	CcSEcCtD
Hyoscyamine—Dry mouth—Triamcinolone—multiple sclerosis	0.00103	0.00115	CcSEcCtD
Hyoscyamine—Angioedema—Dexamethasone—multiple sclerosis	0.00103	0.00114	CcSEcCtD
Hyoscyamine—Angioedema—Betamethasone—multiple sclerosis	0.00103	0.00114	CcSEcCtD
Hyoscyamine—Conjunctivitis—Methotrexate—multiple sclerosis	0.00102	0.00113	CcSEcCtD
Hyoscyamine—Confusional state—Methylprednisolone—multiple sclerosis	0.00102	0.00113	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00101	0.00113	CcSEcCtD
Hyoscyamine—Oedema—Triamcinolone—multiple sclerosis	0.00101	0.00113	CcSEcCtD
Hyoscyamine—Vertigo—Dexamethasone—multiple sclerosis	0.00101	0.00112	CcSEcCtD
Hyoscyamine—Vertigo—Betamethasone—multiple sclerosis	0.00101	0.00112	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00101	0.00112	CcSEcCtD
Hyoscyamine—Syncope—Dexamethasone—multiple sclerosis	0.00101	0.00112	CcSEcCtD
Hyoscyamine—Syncope—Betamethasone—multiple sclerosis	0.00101	0.00112	CcSEcCtD
Hyoscyamine—Arrhythmia—Prednisone—multiple sclerosis	0.001	0.00112	CcSEcCtD
Hyoscyamine—Sweating—Methotrexate—multiple sclerosis	0.001	0.00112	CcSEcCtD
Hyoscyamine—Shock—Triamcinolone—multiple sclerosis	0.000994	0.00111	CcSEcCtD
Hyoscyamine—Insomnia—Prednisolone—multiple sclerosis	0.000993	0.00111	CcSEcCtD
Hyoscyamine—Shock—Methylprednisolone—multiple sclerosis	0.000991	0.00111	CcSEcCtD
Hyoscyamine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000987	0.0011	CcSEcCtD
Hyoscyamine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000987	0.0011	CcSEcCtD
Hyoscyamine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000986	0.0011	CcSEcCtD
Hyoscyamine—Tachycardia—Triamcinolone—multiple sclerosis	0.000986	0.0011	CcSEcCtD
Hyoscyamine—Mental disorder—Prednisone—multiple sclerosis	0.000984	0.0011	CcSEcCtD
Hyoscyamine—Nausea—Azathioprine—multiple sclerosis	0.000984	0.0011	CcSEcCtD
Hyoscyamine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000984	0.0011	CcSEcCtD
Hyoscyamine—Erythema—Prednisone—multiple sclerosis	0.000978	0.00109	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000976	0.00109	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000974	0.00109	CcSEcCtD
Hyoscyamine—Convulsion—Dexamethasone—multiple sclerosis	0.000973	0.00108	CcSEcCtD
Hyoscyamine—Convulsion—Betamethasone—multiple sclerosis	0.000973	0.00108	CcSEcCtD
Hyoscyamine—Asthenia—Mitoxantrone—multiple sclerosis	0.00096	0.00107	CcSEcCtD
Hyoscyamine—Anxiety—Dexamethasone—multiple sclerosis	0.000953	0.00106	CcSEcCtD
Hyoscyamine—Anxiety—Betamethasone—multiple sclerosis	0.000953	0.00106	CcSEcCtD
Hyoscyamine—Hypotension—Methylprednisolone—multiple sclerosis	0.000942	0.00105	CcSEcCtD
Hyoscyamine—Pain—Prednisolone—multiple sclerosis	0.000939	0.00105	CcSEcCtD
Hyoscyamine—Vision blurred—Prednisone—multiple sclerosis	0.000922	0.00103	CcSEcCtD
Hyoscyamine—Oedema—Betamethasone—multiple sclerosis	0.000916	0.00102	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000916	0.00102	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000916	0.00102	CcSEcCtD
Hyoscyamine—Oedema—Dexamethasone—multiple sclerosis	0.000916	0.00102	CcSEcCtD
Hyoscyamine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000916	0.00102	CcSEcCtD
Hyoscyamine—Insomnia—Triamcinolone—multiple sclerosis	0.000913	0.00102	CcSEcCtD
Hyoscyamine—Insomnia—Methylprednisolone—multiple sclerosis	0.000911	0.00102	CcSEcCtD
Hyoscyamine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000905	0.00101	CcSEcCtD
Hyoscyamine—Shock—Betamethasone—multiple sclerosis	0.000902	0.00101	CcSEcCtD
Hyoscyamine—Shock—Dexamethasone—multiple sclerosis	0.000902	0.00101	CcSEcCtD
Hyoscyamine—Dyspnoea—Triamcinolone—multiple sclerosis	0.0009	0.001	CcSEcCtD
Hyoscyamine—Agitation—Prednisone—multiple sclerosis	0.000899	0.001	CcSEcCtD
Hyoscyamine—Tachycardia—Dexamethasone—multiple sclerosis	0.000894	0.000997	CcSEcCtD
Hyoscyamine—Tachycardia—Betamethasone—multiple sclerosis	0.000894	0.000997	CcSEcCtD
Hyoscyamine—Angioedema—Prednisone—multiple sclerosis	0.000894	0.000996	CcSEcCtD
Hyoscyamine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000889	0.000991	CcSEcCtD
Hyoscyamine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000887	0.000989	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000886	0.000988	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000886	0.000988	CcSEcCtD
Hyoscyamine—Vertigo—Prednisone—multiple sclerosis	0.000879	0.00098	CcSEcCtD
Hyoscyamine—Syncope—Prednisone—multiple sclerosis	0.000877	0.000978	CcSEcCtD
Hyoscyamine—Urticaria—Prednisolone—multiple sclerosis	0.000872	0.000973	CcSEcCtD
Hyoscyamine—Fatigue—Triamcinolone—multiple sclerosis	0.000871	0.000971	CcSEcCtD
Hyoscyamine—Fatigue—Methylprednisolone—multiple sclerosis	0.000869	0.000969	CcSEcCtD
Hyoscyamine—Pain—Triamcinolone—multiple sclerosis	0.000864	0.000963	CcSEcCtD
Hyoscyamine—Loss of consciousness—Prednisone—multiple sclerosis	0.000859	0.000958	CcSEcCtD
Hyoscyamine—Hypotension—Dexamethasone—multiple sclerosis	0.000856	0.000955	CcSEcCtD
Hyoscyamine—Hypotension—Betamethasone—multiple sclerosis	0.000856	0.000955	CcSEcCtD
Hyoscyamine—Vomiting—Mitoxantrone—multiple sclerosis	0.000851	0.000949	CcSEcCtD
Hyoscyamine—Convulsion—Prednisone—multiple sclerosis	0.000847	0.000945	CcSEcCtD
Hyoscyamine—Rash—Mitoxantrone—multiple sclerosis	0.000844	0.000941	CcSEcCtD
Hyoscyamine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000843	0.00094	CcSEcCtD
Hyoscyamine—Headache—Mitoxantrone—multiple sclerosis	0.000839	0.000935	CcSEcCtD
Hyoscyamine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000832	0.000928	CcSEcCtD
Hyoscyamine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00083	0.000926	CcSEcCtD
Hyoscyamine—Anxiety—Prednisone—multiple sclerosis	0.00083	0.000925	CcSEcCtD
Hyoscyamine—Insomnia—Dexamethasone—multiple sclerosis	0.000829	0.000924	CcSEcCtD
Hyoscyamine—Insomnia—Betamethasone—multiple sclerosis	0.000829	0.000924	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000824	0.000919	CcSEcCtD
Hyoscyamine—Mental disorder—Methotrexate—multiple sclerosis	0.000822	0.000917	CcSEcCtD
Hyoscyamine—Erythema—Methotrexate—multiple sclerosis	0.000817	0.000911	CcSEcCtD
Hyoscyamine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000809	0.000902	CcSEcCtD
Hyoscyamine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000807	0.000899	CcSEcCtD
Hyoscyamine—Dyspepsia—Betamethasone—multiple sclerosis	0.000807	0.000899	CcSEcCtD
Hyoscyamine—Urticaria—Triamcinolone—multiple sclerosis	0.000802	0.000895	CcSEcCtD
Hyoscyamine—Urticaria—Methylprednisolone—multiple sclerosis	0.000801	0.000893	CcSEcCtD
Hyoscyamine—Dysgeusia—Methotrexate—multiple sclerosis	0.0008	0.000892	CcSEcCtD
Hyoscyamine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000798	0.00089	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000798	0.00089	CcSEcCtD
Hyoscyamine—Oedema—Prednisone—multiple sclerosis	0.000798	0.00089	CcSEcCtD
Hyoscyamine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000797	0.000888	CcSEcCtD
Hyoscyamine—Nausea—Mitoxantrone—multiple sclerosis	0.000795	0.000887	CcSEcCtD
Hyoscyamine—Fatigue—Dexamethasone—multiple sclerosis	0.00079	0.000881	CcSEcCtD
Hyoscyamine—Fatigue—Betamethasone—multiple sclerosis	0.00079	0.000881	CcSEcCtD
Hyoscyamine—Shock—Prednisone—multiple sclerosis	0.000785	0.000875	CcSEcCtD
Hyoscyamine—Pain—Dexamethasone—multiple sclerosis	0.000784	0.000874	CcSEcCtD
Hyoscyamine—Pain—Betamethasone—multiple sclerosis	0.000784	0.000874	CcSEcCtD
Hyoscyamine—Tachycardia—Prednisone—multiple sclerosis	0.000779	0.000868	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000772	0.00086	CcSEcCtD
Hyoscyamine—Vision blurred—Methotrexate—multiple sclerosis	0.00077	0.000859	CcSEcCtD
Hyoscyamine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000755	0.000842	CcSEcCtD
Hyoscyamine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000755	0.000842	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000749	0.000835	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000749	0.000835	CcSEcCtD
Hyoscyamine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000744	0.00083	CcSEcCtD
Hyoscyamine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000742	0.000828	CcSEcCtD
Hyoscyamine—Vertigo—Methotrexate—multiple sclerosis	0.000734	0.000819	CcSEcCtD
Hyoscyamine—Urticaria—Dexamethasone—multiple sclerosis	0.000728	0.000812	CcSEcCtD
Hyoscyamine—Urticaria—Betamethasone—multiple sclerosis	0.000728	0.000812	CcSEcCtD
Hyoscyamine—Dizziness—Prednisolone—multiple sclerosis	0.000726	0.00081	CcSEcCtD
Hyoscyamine—Asthenia—Triamcinolone—multiple sclerosis	0.000725	0.000808	CcSEcCtD
Hyoscyamine—Abdominal pain—Betamethasone—multiple sclerosis	0.000724	0.000808	CcSEcCtD
Hyoscyamine—Body temperature increased—Betamethasone—multiple sclerosis	0.000724	0.000808	CcSEcCtD
Hyoscyamine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000724	0.000808	CcSEcCtD
Hyoscyamine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000724	0.000808	CcSEcCtD
Hyoscyamine—Asthenia—Methylprednisolone—multiple sclerosis	0.000723	0.000806	CcSEcCtD
Hyoscyamine—Insomnia—Prednisone—multiple sclerosis	0.000722	0.000805	CcSEcCtD
Hyoscyamine—Pruritus—Triamcinolone—multiple sclerosis	0.000715	0.000797	CcSEcCtD
Hyoscyamine—Pruritus—Methylprednisolone—multiple sclerosis	0.000713	0.000795	CcSEcCtD
Hyoscyamine—Convulsion—Methotrexate—multiple sclerosis	0.000708	0.000789	CcSEcCtD
Hyoscyamine—Dyspepsia—Prednisone—multiple sclerosis	0.000703	0.000783	CcSEcCtD
Hyoscyamine—Chest pain—Methotrexate—multiple sclerosis	0.000696	0.000776	CcSEcCtD
Hyoscyamine—Rash—Prednisolone—multiple sclerosis	0.000692	0.000772	CcSEcCtD
Hyoscyamine—Dermatitis—Prednisolone—multiple sclerosis	0.000692	0.000771	CcSEcCtD
Hyoscyamine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000689	0.000769	CcSEcCtD
Hyoscyamine—Fatigue—Prednisone—multiple sclerosis	0.000688	0.000767	CcSEcCtD
Hyoscyamine—Headache—Prednisolone—multiple sclerosis	0.000688	0.000767	CcSEcCtD
Hyoscyamine—Constipation—Prednisone—multiple sclerosis	0.000682	0.000761	CcSEcCtD
Hyoscyamine—Confusional state—Methotrexate—multiple sclerosis	0.000673	0.00075	CcSEcCtD
Hyoscyamine—Dizziness—Triamcinolone—multiple sclerosis	0.000668	0.000745	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000667	0.000744	CcSEcCtD
Hyoscyamine—Dizziness—Methylprednisolone—multiple sclerosis	0.000666	0.000743	CcSEcCtD
Hyoscyamine—Feeling abnormal—Prednisone—multiple sclerosis	0.000658	0.000733	CcSEcCtD
Hyoscyamine—Asthenia—Dexamethasone—multiple sclerosis	0.000658	0.000733	CcSEcCtD
Hyoscyamine—Asthenia—Betamethasone—multiple sclerosis	0.000658	0.000733	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000653	0.000728	CcSEcCtD
Hyoscyamine—Nausea—Prednisolone—multiple sclerosis	0.000652	0.000727	CcSEcCtD
Hyoscyamine—Pruritus—Dexamethasone—multiple sclerosis	0.000648	0.000723	CcSEcCtD
Hyoscyamine—Pruritus—Betamethasone—multiple sclerosis	0.000648	0.000723	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000645	0.000719	CcSEcCtD
Hyoscyamine—Vomiting—Triamcinolone—multiple sclerosis	0.000642	0.000716	CcSEcCtD
Hyoscyamine—Vomiting—Methylprednisolone—multiple sclerosis	0.000641	0.000714	CcSEcCtD
Hyoscyamine—Rash—Triamcinolone—multiple sclerosis	0.000637	0.00071	CcSEcCtD
Hyoscyamine—Dermatitis—Triamcinolone—multiple sclerosis	0.000636	0.000709	CcSEcCtD
Hyoscyamine—Rash—Methylprednisolone—multiple sclerosis	0.000635	0.000708	CcSEcCtD
Hyoscyamine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000635	0.000708	CcSEcCtD
Hyoscyamine—Urticaria—Prednisone—multiple sclerosis	0.000634	0.000707	CcSEcCtD
Hyoscyamine—Headache—Triamcinolone—multiple sclerosis	0.000633	0.000705	CcSEcCtD
Hyoscyamine—Headache—Methylprednisolone—multiple sclerosis	0.000631	0.000704	CcSEcCtD
Hyoscyamine—Abdominal pain—Prednisone—multiple sclerosis	0.000631	0.000703	CcSEcCtD
Hyoscyamine—Body temperature increased—Prednisone—multiple sclerosis	0.000631	0.000703	CcSEcCtD
Hyoscyamine—Diarrhoea—Betamethasone—multiple sclerosis	0.000627	0.000699	CcSEcCtD
Hyoscyamine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000627	0.000699	CcSEcCtD
Hyoscyamine—Hypotension—Methotrexate—multiple sclerosis	0.000623	0.000695	CcSEcCtD
Hyoscyamine—Dizziness—Betamethasone—multiple sclerosis	0.000606	0.000676	CcSEcCtD
Hyoscyamine—Dizziness—Dexamethasone—multiple sclerosis	0.000606	0.000676	CcSEcCtD
Hyoscyamine—Insomnia—Methotrexate—multiple sclerosis	0.000603	0.000673	CcSEcCtD
Hyoscyamine—Nausea—Triamcinolone—multiple sclerosis	0.0006	0.000669	CcSEcCtD
Hyoscyamine—Nausea—Methylprednisolone—multiple sclerosis	0.000599	0.000667	CcSEcCtD
Hyoscyamine—Dyspnoea—Methotrexate—multiple sclerosis	0.000595	0.000663	CcSEcCtD
Hyoscyamine—Somnolence—Methotrexate—multiple sclerosis	0.000593	0.000661	CcSEcCtD
Hyoscyamine—Hypersensitivity—Prednisone—multiple sclerosis	0.000588	0.000656	CcSEcCtD
Hyoscyamine—Dyspepsia—Methotrexate—multiple sclerosis	0.000587	0.000655	CcSEcCtD
Hyoscyamine—Vomiting—Betamethasone—multiple sclerosis	0.000583	0.00065	CcSEcCtD
Hyoscyamine—Vomiting—Dexamethasone—multiple sclerosis	0.000583	0.00065	CcSEcCtD
Hyoscyamine—Rash—Dexamethasone—multiple sclerosis	0.000578	0.000644	CcSEcCtD
Hyoscyamine—Rash—Betamethasone—multiple sclerosis	0.000578	0.000644	CcSEcCtD
Hyoscyamine—Dermatitis—Dexamethasone—multiple sclerosis	0.000577	0.000644	CcSEcCtD
Hyoscyamine—Dermatitis—Betamethasone—multiple sclerosis	0.000577	0.000644	CcSEcCtD
Hyoscyamine—Fatigue—Methotrexate—multiple sclerosis	0.000575	0.000641	CcSEcCtD
Hyoscyamine—Headache—Dexamethasone—multiple sclerosis	0.000574	0.00064	CcSEcCtD
Hyoscyamine—Headache—Betamethasone—multiple sclerosis	0.000574	0.00064	CcSEcCtD
Hyoscyamine—Asthenia—Prednisone—multiple sclerosis	0.000573	0.000638	CcSEcCtD
Hyoscyamine—Pain—Methotrexate—multiple sclerosis	0.00057	0.000636	CcSEcCtD
Hyoscyamine—Pruritus—Prednisone—multiple sclerosis	0.000565	0.00063	CcSEcCtD
Hyoscyamine—Feeling abnormal—Methotrexate—multiple sclerosis	0.00055	0.000613	CcSEcCtD
Hyoscyamine—Diarrhoea—Prednisone—multiple sclerosis	0.000546	0.000609	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000545	0.000608	CcSEcCtD
Hyoscyamine—Nausea—Betamethasone—multiple sclerosis	0.000544	0.000607	CcSEcCtD
Hyoscyamine—Nausea—Dexamethasone—multiple sclerosis	0.000544	0.000607	CcSEcCtD
Hyoscyamine—Urticaria—Methotrexate—multiple sclerosis	0.00053	0.000591	CcSEcCtD
Hyoscyamine—Dizziness—Prednisone—multiple sclerosis	0.000528	0.000588	CcSEcCtD
Hyoscyamine—Abdominal pain—Methotrexate—multiple sclerosis	0.000527	0.000588	CcSEcCtD
Hyoscyamine—Body temperature increased—Methotrexate—multiple sclerosis	0.000527	0.000588	CcSEcCtD
Hyoscyamine—Vomiting—Prednisone—multiple sclerosis	0.000507	0.000566	CcSEcCtD
Hyoscyamine—Rash—Prednisone—multiple sclerosis	0.000503	0.000561	CcSEcCtD
Hyoscyamine—Dermatitis—Prednisone—multiple sclerosis	0.000503	0.00056	CcSEcCtD
Hyoscyamine—Headache—Prednisone—multiple sclerosis	0.0005	0.000557	CcSEcCtD
Hyoscyamine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000491	0.000548	CcSEcCtD
Hyoscyamine—Asthenia—Methotrexate—multiple sclerosis	0.000479	0.000534	CcSEcCtD
Hyoscyamine—Nausea—Prednisone—multiple sclerosis	0.000474	0.000529	CcSEcCtD
Hyoscyamine—Pruritus—Methotrexate—multiple sclerosis	0.000472	0.000526	CcSEcCtD
Hyoscyamine—Diarrhoea—Methotrexate—multiple sclerosis	0.000456	0.000509	CcSEcCtD
Hyoscyamine—Dizziness—Methotrexate—multiple sclerosis	0.000441	0.000492	CcSEcCtD
Hyoscyamine—Vomiting—Methotrexate—multiple sclerosis	0.000424	0.000473	CcSEcCtD
Hyoscyamine—Rash—Methotrexate—multiple sclerosis	0.000421	0.000469	CcSEcCtD
Hyoscyamine—Dermatitis—Methotrexate—multiple sclerosis	0.00042	0.000468	CcSEcCtD
Hyoscyamine—Headache—Methotrexate—multiple sclerosis	0.000418	0.000466	CcSEcCtD
Hyoscyamine—Nausea—Methotrexate—multiple sclerosis	0.000396	0.000442	CcSEcCtD
Hyoscyamine—CHRM3—Metabolism—GPC5—multiple sclerosis	0.000151	0.0015	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—CCL2—multiple sclerosis	0.000149	0.00149	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TAGAP—multiple sclerosis	0.000149	0.00148	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TAGAP—multiple sclerosis	0.000148	0.00148	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TAGAP—multiple sclerosis	0.000147	0.00146	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CCL5—multiple sclerosis	0.000146	0.00145	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CCL5—multiple sclerosis	0.000145	0.00145	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CCL5—multiple sclerosis	0.000144	0.00143	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CNR1—multiple sclerosis	0.000143	0.00143	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCR1—multiple sclerosis	0.000142	0.00142	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCL13—multiple sclerosis	0.000142	0.00142	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000142	0.00142	CbGpPWpGaD
Hyoscyamine—CHRM1—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	0.000138	0.00138	CbGpPWpGaD
Hyoscyamine—CHRM3—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	0.000138	0.00137	CbGpPWpGaD
Hyoscyamine—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	0.000136	0.00136	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000135	0.00134	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000134	0.00134	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000133	0.00133	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000132	0.00131	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000131	0.00131	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CCR5—multiple sclerosis	0.000131	0.00131	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CCR5—multiple sclerosis	0.000131	0.00131	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00013	0.0013	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—S1PR1—multiple sclerosis	0.00013	0.0013	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	0.00013	0.00129	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—S1PR1—multiple sclerosis	0.00013	0.00129	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CXCL10—multiple sclerosis	0.000129	0.00129	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	0.000128	0.00128	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—GPC5—multiple sclerosis	0.000127	0.00126	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—GPC5—multiple sclerosis	0.000126	0.00126	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000125	0.00125	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—RRM1—multiple sclerosis	0.000125	0.00125	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	0.000125	0.00125	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000123	0.00122	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000122	0.00122	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CCL5—multiple sclerosis	0.000122	0.00122	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000121	0.00121	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000118	0.00118	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000118	0.00118	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000117	0.00117	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.000116	0.00115	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL3—multiple sclerosis	0.000115	0.00115	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000115	0.00115	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CCR2—multiple sclerosis	0.000115	0.00114	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	0.000114	0.00114	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000114	0.00113	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000111	0.00111	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PTGER4—multiple sclerosis	0.000111	0.00111	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CCL5—multiple sclerosis	0.000111	0.00111	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—RGS1—multiple sclerosis	0.000111	0.0011	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—RGS1—multiple sclerosis	0.00011	0.0011	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CCR5—multiple sclerosis	0.00011	0.0011	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	0.00011	0.0011	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	0.000109	0.00109	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000108	0.00108	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000108	0.00107	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCR3—multiple sclerosis	0.000107	0.00107	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000106	0.00106	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000106	0.00106	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CNR1—multiple sclerosis	0.000106	0.00106	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000105	0.00105	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—GPR65—multiple sclerosis	0.000105	0.00105	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	0.000105	0.00104	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—GPR65—multiple sclerosis	0.000104	0.00104	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCR2—multiple sclerosis	0.000104	0.00104	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	0.000103	0.00103	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	0.000103	0.00103	CbGpPWpGaD
Hyoscyamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000103	0.00103	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	0.000103	0.00102	CbGpPWpGaD
Hyoscyamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000103	0.00102	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—POMC—multiple sclerosis	0.000102	0.00102	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	0.000101	0.00101	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL3—multiple sclerosis	0.000101	0.00101	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000101	0.00101	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	0.0001	0.001	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CCL2—multiple sclerosis	0.0001	0.000998	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CCR5—multiple sclerosis	9.99e-05	0.000997	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	9.91e-05	0.000988	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—IL2RA—multiple sclerosis	9.85e-05	0.000982	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PTGER4—multiple sclerosis	9.75e-05	0.000972	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	9.65e-05	0.000962	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CNR1—multiple sclerosis	9.62e-05	0.000959	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PGR—multiple sclerosis	9.6e-05	0.000958	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	9.59e-05	0.000956	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	9.59e-05	0.000956	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	9.57e-05	0.000954	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCL13—multiple sclerosis	9.56e-05	0.000953	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCR1—multiple sclerosis	9.56e-05	0.000953	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CXCL10—multiple sclerosis	9.54e-05	0.000951	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	9.53e-05	0.00095	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	9.46e-05	0.000944	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	9.46e-05	0.000944	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	9.45e-05	0.000942	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCR3—multiple sclerosis	9.42e-05	0.000939	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CD28—multiple sclerosis	9.33e-05	0.00093	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCR2—multiple sclerosis	9.16e-05	0.000914	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	8.69e-05	0.000866	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCL10—multiple sclerosis	8.66e-05	0.000864	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—POMC—multiple sclerosis	8.6e-05	0.000858	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	8.58e-05	0.000855	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CNR1—multiple sclerosis	8.46e-05	0.000843	CbGpPWpGaD
Hyoscyamine—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	8.35e-05	0.000832	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	8.24e-05	0.000821	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CCL5—multiple sclerosis	8.21e-05	0.000819	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	8.13e-05	0.000811	CbGpPWpGaD
Hyoscyamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	7.91e-05	0.000789	CbGpPWpGaD
Hyoscyamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	7.88e-05	0.000786	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—POMC—multiple sclerosis	7.81e-05	0.000779	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CCL2—multiple sclerosis	7.64e-05	0.000762	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCL10—multiple sclerosis	7.61e-05	0.000759	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	7.48e-05	0.000746	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	7.46e-05	0.000744	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	7.42e-05	0.00074	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	7.4e-05	0.000738	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	7.38e-05	0.000736	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	7.33e-05	0.00073	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	7.31e-05	0.000729	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	7.29e-05	0.000727	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	7.22e-05	0.00072	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—BCHE—multiple sclerosis	7.18e-05	0.000716	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—TYK2—multiple sclerosis	6.94e-05	0.000692	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	6.83e-05	0.000681	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	6.81e-05	0.000679	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	6.74e-05	0.000672	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	6.74e-05	0.000672	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	6.72e-05	0.00067	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CD86—multiple sclerosis	6.66e-05	0.000664	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	6.65e-05	0.000663	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	6.64e-05	0.000662	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	6.62e-05	0.00066	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	6.58e-05	0.000656	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	6.56e-05	0.000654	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	6.55e-05	0.000654	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL5—multiple sclerosis	6.55e-05	0.000653	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	6.49e-05	0.000647	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PGR—multiple sclerosis	6.48e-05	0.000646	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PGR—multiple sclerosis	6.46e-05	0.000644	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PGR—multiple sclerosis	6.39e-05	0.000637	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—IL2—multiple sclerosis	6.36e-05	0.000634	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	6.35e-05	0.000633	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	6.33e-05	0.000631	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CD28—multiple sclerosis	6.29e-05	0.000627	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CD28—multiple sclerosis	6.27e-05	0.000625	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	6.27e-05	0.000625	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CD28—multiple sclerosis	6.21e-05	0.000619	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	6.18e-05	0.000616	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	6.16e-05	0.000614	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	6.1e-05	0.000608	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SPP1—multiple sclerosis	6.07e-05	0.000605	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCR5—multiple sclerosis	5.9e-05	0.000589	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL2RA—multiple sclerosis	5.82e-05	0.00058	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	5.8e-05	0.000578	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	5.78e-05	0.000576	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—IL2—multiple sclerosis	5.77e-05	0.000576	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	5.73e-05	0.000571	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	5.7e-05	0.000569	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	5.68e-05	0.000567	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	5.63e-05	0.000561	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—APOE—multiple sclerosis	5.37e-05	0.000536	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	5.27e-05	0.000525	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	5.25e-05	0.000524	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	5.2e-05	0.000518	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	5.15e-05	0.000514	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	5.14e-05	0.000512	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	5.13e-05	0.000512	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	5.12e-05	0.00051	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	5.09e-05	0.000507	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	5.07e-05	0.000505	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CD80—multiple sclerosis	4.86e-05	0.000484	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	4.68e-05	0.000467	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	4.66e-05	0.000465	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	4.62e-05	0.000461	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—POMC—multiple sclerosis	4.61e-05	0.00046	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL2—multiple sclerosis	4.51e-05	0.00045	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CD86—multiple sclerosis	4.49e-05	0.000448	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CD86—multiple sclerosis	4.47e-05	0.000446	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CD86—multiple sclerosis	4.43e-05	0.000442	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	4.42e-05	0.000441	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—MAPK1—multiple sclerosis	4.42e-05	0.00044	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	4.4e-05	0.000439	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	4.36e-05	0.000435	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—APOE—multiple sclerosis	4.32e-05	0.000431	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	4.29e-05	0.000428	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	4.27e-05	0.000426	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	4.23e-05	0.000422	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TYK2—multiple sclerosis	4.1e-05	0.000409	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	4.09e-05	0.000408	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	4.08e-05	0.000407	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	4.04e-05	0.000403	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	3.98e-05	0.000397	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	3.97e-05	0.000396	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	3.93e-05	0.000392	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	3.92e-05	0.000391	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	3.91e-05	0.00039	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	3.89e-05	0.000388	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	3.88e-05	0.000387	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	3.87e-05	0.000386	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	3.84e-05	0.000383	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—POMC—multiple sclerosis	3.71e-05	0.00037	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APOE—multiple sclerosis	3.62e-05	0.000361	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APOE—multiple sclerosis	3.61e-05	0.00036	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	3.58e-05	0.000356	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL2—multiple sclerosis	3.41e-05	0.00034	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	3.39e-05	0.000338	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ALB—multiple sclerosis	3.38e-05	0.000337	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CD80—multiple sclerosis	3.27e-05	0.000327	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CD80—multiple sclerosis	3.26e-05	0.000325	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	3.23e-05	0.000322	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	3.23e-05	0.000322	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—POMC—multiple sclerosis	3.11e-05	0.00031	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—POMC—multiple sclerosis	3.1e-05	0.000309	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	3.07e-05	0.000306	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	3.04e-05	0.000304	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	3.03e-05	0.000303	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	3.01e-05	0.0003	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	2.98e-05	0.000297	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	2.97e-05	0.000296	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	2.94e-05	0.000293	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	2.87e-05	0.000286	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	2.76e-05	0.000276	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	2.76e-05	0.000275	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	2.73e-05	0.000272	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MYC—multiple sclerosis	2.67e-05	0.000266	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	2.66e-05	0.000265	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	2.61e-05	0.00026	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL2—multiple sclerosis	2.3e-05	0.000229	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL2—multiple sclerosis	2.29e-05	0.000229	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	2.29e-05	0.000228	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	2.28e-05	0.000227	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	2.27e-05	0.000226	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	2.26e-05	0.000225	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	2.18e-05	0.000217	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	2.17e-05	0.000216	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	2.15e-05	0.000214	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL6—multiple sclerosis	2.01e-05	0.0002	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	1.94e-05	0.000193	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	1.93e-05	0.000192	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	1.91e-05	0.000191	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MYC—multiple sclerosis	1.8e-05	0.000179	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	1.79e-05	0.000179	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MYC—multiple sclerosis	1.79e-05	0.000179	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	1.79e-05	0.000178	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	1.78e-05	0.000177	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	1.77e-05	0.000177	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	1.76e-05	0.000175	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	1.75e-05	0.000175	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	1.74e-05	0.000173	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL6—multiple sclerosis	1.35e-05	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL6—multiple sclerosis	1.35e-05	0.000134	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	1.33e-05	0.000133	CbGpPWpGaD
